Filed with the SEC on · accession 0001193125-26-456989
ASND filed a 6-K (foreign company report) with the SEC on Nov 12, 2026. How foreign companies listed in the US report news and events — like an 8-K for them.
Ascendis Pharma A/S furnished a Form 6-K announcing its financial results for the fiscal quarter ended September 30, 2026, via an attached press release dated November 12, 2026.
✦ Ask GOAX AI about this filing — what it means for ASND, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ASND?
Click hereASND filed a 6-K (SEC filing). Ascendis Pharma A/S furnished a Form 6-K announcing its financial results for the fiscal quarter ended September 30, 2026, via an attached press release dated November 12, 2026.
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
Get alerts when ASND files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days